Keywords: Hospira, Posidur, DURECT, USA. Canada, Post-operative pain, License rights returned

Hospira returns Posidur rights to DURECT

Article | 02 April 2012

Print This

DURECT Corp (Nasdaq: DRRX) says that fellow USA-based that Hospira (NYSE: HSP) has given notice that it is returning its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in